Rarres1, retinoic acid receptor responder protein 1, is a gene involved in various biological processes. It has been associated with functions such as regulating mitochondrial and fatty acid metabolism, stem cell differentiation, and cell survival [2,3]. Rarres1 may also play a role in pathways related to tubulin deglutamylation, which in turn impacts mitochondrial function and energy balance [3].

In mouse models, the constitutive knockout of Rarres1 (Rarres1 -/-) led to a markedly increased dose-dependent incidence of follicular lymphoma (FL) and inhibited B cell differentiation. Prior to lymphoma formation, Rarres1 -/- B cells had compromised activation, maturation, and cell cycle progression [2]. In the context of kidney diseases, podocyte-specific overexpression of RARRES1 in mice resulted in marked glomerular injury and albuminuria, while podocyte-specific knockdown of Rarres1 ameliorated glomerular injury in adriamycin-induced nephropathy [1].

In conclusion, Rarres1 plays crucial roles in multiple biological processes and diseases. Mouse models, especially gene knockout models, have significantly contributed to understanding its role in follicular lymphoma development, B cell differentiation, and glomerular disease progression. These findings provide insights into potential therapeutic targets for related diseases.